MPM Capital

MPM Capital is an investment firm devoted to biotechnology. It says it has three decades of experience, and it calls itself a company creator that turns scientific findings into treatments for patients with serious unmet needs.

What MPM Capital offers

• Company creation: it founds and builds biotechnology firms, using entrepreneurs with expertise in research, intellectual property, clinical strategy and commercialisation.
• Early-stage venture funds: managed by MPM directly.
• Impact funds: private and public funds run by its affiliate manager, BioImpact Capital.
• Public equities fund: also handled by BioImpact Capital.

Who it works with

Drug developers across the process. Examples on its site include Aktis Oncology (targeted radiopharmaceuticals), Dyne Therapeutics (RNA-based therapies for neuromuscular disorders), ElevateBio (cell and gene therapy), Cullinan Oncology and Blade Therapeutics (fibrosis).

Key facts

• Experience: About three decades
• Affiliate: BioImpact Capital
• Team: Physicians and scientists among the partners